Ovintiv Maintained at Buy at TPH Ahead of Q3 Results; Price Target at US$63.00
In this article:
Ovintiv Maintained at Buy at TPH Ahead of Q3 Results; Price Target at US$63.00
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.